Table 2.
OVERALL n (%) | TRAIN SET n (%) | VALID SET n (%) | TEST SET n (%) | |
---|---|---|---|---|
HISTOLOGIC SUBTYPE | 287 | 199 | 44 | 44 |
Undifferentiated Pleomorphic Sarcoma | 87 (30.5) | 61 (30.7) | 15 (35.7) | 11 (25.0) |
Myxofibrosarcoma | 63 (22.1) | 40 (20.1) | 13 (31.0) | 10 (22.7) |
Myxoid Liposarcoma | 33 (11.6) | 24 (12.1) | 3 (7.1) | 6 (13.6) |
Synovial sarcoma | 35 (12.3) | 23 (11.6) | 3 (7.1) | 9 (20.5) |
Liposarcoma | 22 (7.7) | 16 (8.0) | 2 (4.8) | 4 (9.1) |
Leiomyosarcoma | 8 (2.8) | 5 (2.5) | 1 (2.4) | 2 (4.5) |
Rhabdomyosarcoma | 6 (2.1) | 5 (2.5) | 1 (2.4) | |
Myxoinflammatory Fibroblastic sarcoma | 6 (2.1) | 4 (2.0) | 2 (4.8) | |
MPNST | 5 (1.8) | 2 (1.0) | 3 (7.1) | |
Ewings of soft tissue | 4 (1.4) | 4 (2.0) | ||
Solitary Fibrous Tumor | 4 (1.4) | 4 (2.0) | ||
Extraskeletal Myxoid Chondrosarcoma | 4 (1.4) | 2 (1.0) | 2 (4.5) | |
Extraskeletal Osteosarcoma | 3 (1.1) | 3 (1.0) | ||
ASPS | 2 (0.7) | 2 (1.0) | ||
Spindle cell sarcoma | 2 (0.7) | 2 (1.0) | ||
Clear cell sarcoma | 1 (0.3) | 1 (2.4) | ||
Epithelioid sarcoma | 1 (0.3) | 1 (1.5) | ||
Fibrosarcoma | 1 (0.3) | 1 (1.0) |
Subtype is based on the final pathology report.